Cardiovascular - Diabetic
Box of 3 blisters x 10 film - coated tablets
LOJECDAT
Indications:
Treatment of essential hypertension.
Lojecdat is indicated in patients whose blood pressure is well controlled on concomitant administration of Nebivolol 5 mg and hydrochlorothiazide 12.5 mg.
Ingredient:
Nebivolol 5 mg / hydrochlorothiazide 12.5 mg